AIMC Topic: Biomarkers, Tumor

Clear Filters Showing 101 to 110 of 1403 articles

Single-cell RNA sequencing identifies CD8Teff cell activation as a predictive biomarker in triple-negative breast cancer immunotherapy.

Molecular biomedicine
Immunotherapy has emerged as a promising treatment option for triple-negative breast cancer (TNBC); however, the pronounced heterogeneity of the tumor immune microenvironment significantly hinders the prediction of therapeutic efficacy, with effectiv...

From biosensing to perception: Collaborative few-shot learning for explainable digital biomarker identification in high-dimensional biomedical spectra.

Biosensors & bioelectronics
The application of in vitro diagnostic biosensors for early cancer detection remains challenging due to the insufficient representation by a few molecular biomarkers. Digital biomarkers promise comprehensive disease phenotyping but face constraints o...

Identification and predictive machine learning model construction of gut microbiota associated with carcinoembryonic antigens in colorectal cancer.

mSphere
UNLABELLED: Carcinoembryonic antigen (CEA) is a critical colorectal cancer (CRC) biomarker, but its mechanistic link to gut microbiota remains unclear. This study characterized gut microbiota differences between high-CEA (H-CEA) and low-CEA (L-CEA) C...

Differentiating Gastric Cancers from Acid Peptic Diseases through Integrative Targeted Proteomics and Machine Learning Approaches.

Journal of proteome research
Gastric cancers (GCs) are often diagnosed in advanced stages owing to nonspecific early symptoms resembling Acid Peptic Diseases (APDs). Despite recent efforts, a simple, liquid biopsy-based multiprotein panel prediagnostic assay capable of different...

Development of a prostate cancer biochemical recurrence risk signature using machine learning and motor protein-related genes.

PloS one
BACKGROUND: Motor proteins play significant roles in cancer progression, but their involvement in biochemical recurrence (BCR) of prostate cancer remains unclear. The objective of the study is to develop a prognostic indicator for BCR using machine l...

Cutting-edge nanobiosensors: Revolutionizing cancer diagnosis and enabling precision medicine.

Clinica chimica acta; international journal of clinical chemistry
Integrating nanotechnology and artificial intelligence (AI) revolutionizes cancer diagnostics, propelling precision medicine into a transformative era. This review examines state-of-the-art nanobiosensors capable of detecting critical biomarkers-circ...

Immune-enhanced machine learning approach for early detection of precancerous colorectal neoplasia: Insights from biomarkers in routine health checkups.

European journal of cancer (Oxford, England : 1990)
BACKGROUND AND AIMS: Current screening strategies for colorectal cancer (CRC) rely on colonoscopy, an invasive procedure with limited capacity to address individual risk. There is growing interest in integrating noninvasive immune biomarkers to impro...

Construction and multi-omics analysis of ccRCC mitochondrial related gene machine learning model and validate of key gene FKBP10.

International immunopharmacology
BACKGROUND: Clear cell renal cell carcinoma represents the most prevalent histological subtype of renal malignancy Emerging evidence underscores the critical involvement of mitochondrial dysfunction in oncogenesis and tumor progression. In this study...

Plasma Proteomic High-Performance Biomarkers for Early Diagnosis of Colorectal Cancer.

Journal of proteome research
Colorectal cancer (CRC) is a major global health challenge due to its high incidence, mortality, and low rate of early detection. Early diagnosis, targeting precancerous lesions (advanced adenomas) and early stage CRC (Tis and T1), is critical for im...

KPNA2 expression as a biomarker for immunosuppressive microenvironment predicting response to TKI and immunotherapy in metastatic renal cell carcinoma.

European journal of pharmacology
BACKGROUND: Immunotherapy (IO) combined with tyrosine kinase inhibitors (TKI) are now first-line therapy for advanced renal cell carcinoma (RCC), though reliable predictive biomarkers remain elusive. Recent evidence demonstrates that karyopherin α2 s...